Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ozasa H et al. – The alteration of molecular pharmacological factors in relation with pemetrexed resistance is dose–dependent, and that up–regulation of the expression of the TS gene may have an important role in the acquired resistance to pemetrexed. In addition, TS may be a predictive marker for pemetrexed sensitivity in lung cancer.

Today in Lung/Thoracic Oncology...keeping you current

A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09

Fhit regulates invasion of lung tumor cells
Oncogene, 11/25/09

Choroidal metastases from lung adenocarcinoma
Clinical and Translational Oncology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address